Radiation therapy firm Varian Medical Systems said it has formed the Adaptive Intelligence Consortium, a global consortium of clinicians and scientists that will work together to create evidence-based best practices for adaptive radiotherapy.
The consortium will lead clinical trials to develop clinical protocols for Varian's adaptive radiotherapy technology. The company is currently developing an artificial intelligence (AI)-based multimodality adaptive radiotherapy treatment suite that will incorporate MR, PET, and CT imaging.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
